ID   S12A3_RAT               Reviewed;        1002 AA.
AC   P55018;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   13-DEC-2002, sequence version 2.
DT   02-OCT-2024, entry version 147.
DE   RecName: Full=Solute carrier family 12 member 3;
DE   AltName: Full=Na-Cl symporter;
DE   AltName: Full=Thiazide-sensitive sodium-chloride cotransporter;
GN   Name=Slc12a3; Synonyms=Tsc {ECO:0000303|PubMed:10894798};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORT ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney cortex;
RX   PubMed=8021284; DOI=10.1016/s0021-9258(17)32499-7;
RA   Gamba G., Miyanoshita A., Lombardi M., Lytton J., Lee W.S., Hediger M.A.,
RA   Hebert S.C.;
RT   "Molecular cloning, primary structure, and characterization of two members
RT   of the mammalian electroneutral sodium-(potassium)-chloride cotransporter
RT   family expressed in kidney.";
RL   J. Biol. Chem. 269:17713-17722(1994).
RN   [2]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=10894798; DOI=10.1152/ajprenal.2000.279.1.f161;
RA   Monroy A., Plata C., Hebert S.C., Gamba G.;
RT   "Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a
RT   new model for ions and diuretics interaction.";
RL   Am. J. Physiol. 279:F161-F169(2000).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-53; THR-58 AND
RP   SER-71, GLYCOSYLATION AT ASN-404 AND ASN-424, AND MUTAGENESIS OF THR-53;
RP   THR-58; SER-71; ASN-404 AND ASN-424.
RX   PubMed=16887815; DOI=10.1074/jbc.m603773200;
RA   Pacheco-Alvarez D., Cristobal P.S., Meade P., Moreno E., Vazquez N.,
RA   Munoz E., Diaz A., Juarez M.E., Gimenez I., Gamba G.;
RT   "The Na+:Cl- cotransporter is activated and phosphorylated at the amino-
RT   terminal domain upon intracellular chloride depletion.";
RL   J. Biol. Chem. 281:28755-28763(2006).
CC   -!- FUNCTION: Electroneutral sodium and chloride ion cotransporter, which
CC       acts as a key mediator of sodium and chloride reabsorption in kidney
CC       distal convoluted tubules (PubMed:10894798, PubMed:16887815,
CC       PubMed:8021284). Also acts as a receptor for the pro-inflammatory
CC       cytokine IL18, thereby contributing to IL18-induced cytokine
CC       production, including IFNG, IL6, IL18 and CCL2. May act either
CC       independently of IL18R1, or in a complex with IL18R1 (By similarity).
CC       {ECO:0000250|UniProtKB:P59158, ECO:0000269|PubMed:10894798,
CC       ECO:0000269|PubMed:16887815, ECO:0000269|PubMed:8021284}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(out) + Na(+)(out) = chloride(in) + Na(+)(in);
CC         Xref=Rhea:RHEA:73887, ChEBI:CHEBI:17996, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:10894798, ECO:0000269|PubMed:8021284};
CC   -!- ACTIVITY REGULATION: Phosphorylation by OXSR1/OSR1 and STK39/SPAK in
CC       kidney distal convoluted tubules downstream of WNK4 promotes its
CC       activity (PubMed:16887815). Also activated by OXSR1/OSR1 and STK39/SPAK
CC       downstream of WNK3 (By similarity). Activated by isotonic conditions
CC       (PubMed:10894798). Inhibited by thiazide-type diuretics including
CC       polythiazide, metolazone, bendroflumethiazide, trichloromethiazide,
CC       hydrochlorothiazide and chlorthalidone (PubMed:10894798). Thiazide
CC       drugs specifically inhibit SLC12A3/NCC transporter activity by
CC       competing with chloride for binding (By similarity).
CC       {ECO:0000250|UniProtKB:P55017, ECO:0000269|PubMed:10894798,
CC       ECO:0000269|PubMed:16887815}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.29 mM for Na(+) {ECO:0000269|PubMed:10894798};
CC         KM=6.48 mM for Cl(-) {ECO:0000269|PubMed:10894798};
CC   -!- SUBUNIT: Homodimer; adopts a domain-swap conformation at the scissor
CC       helices connecting the transmembrane domain and C-terminal domain (By
CC       similarity). Interacts with KLHL3 (By similarity). Interacts with
CC       IL18R1; this interaction is increased by IL18 treatment (By
CC       similarity). {ECO:0000250|UniProtKB:P55017,
CC       ECO:0000250|UniProtKB:P59158}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16887815};
CC       Multi-pass membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:P59158}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, predominantly in the outer
CC       cortex in short tubule segments. {ECO:0000269|PubMed:8021284}.
CC   -!- DOMAIN: Interaction between the cytoplasmic N-terminal and C-terminal
CC       domains (NTD and CTD, respectively) is essential for SLC12A3/NCC
CC       transporter activity. Phosphorylation by OXSR1/OSR1 and STK39/SPAK may
CC       activate SLC12A3/NCC by facilitating this interaction.
CC       {ECO:0000250|UniProtKB:P55017}.
CC   -!- PTM: Ubiquitinated; ubiquitination is essential for regulation of
CC       endocytosis. {ECO:0000250|UniProtKB:P59158}.
CC   -!- PTM: Phosphorylated at Thr-53, Thr-58 and Ser-71 by OXSR1/OSR1 and
CC       STK39/SPAK downstream of WNK4, promoting its activity
CC       (PubMed:16887815). Phosphorylated in response to IL18 (By similarity).
CC       {ECO:0000250|UniProtKB:P59158, ECO:0000269|PubMed:16887815}.
CC   -!- SIMILARITY: Belongs to the SLC12A transporter family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10097; AAA21252.2; -; mRNA.
DR   PIR; B54145; B54145.
DR   RefSeq; NP_062218.3; NM_019345.3.
DR   AlphaFoldDB; P55018; -.
DR   SMR; P55018; -.
DR   BioGRID; 248520; 3.
DR   STRING; 10116.ENSRNOP00000070064; -.
DR   TCDB; 2.A.30.1.11; the cation-chloride cotransporter (ccc) family.
DR   GlyCosmos; P55018; 2 sites, No reported glycans.
DR   GlyGen; P55018; 2 sites.
DR   iPTMnet; P55018; -.
DR   PhosphoSitePlus; P55018; -.
DR   PaxDb; 10116-ENSRNOP00000025377; -.
DR   Ensembl; ENSRNOT00055038354; ENSRNOP00055031223; ENSRNOG00055022313.
DR   Ensembl; ENSRNOT00060028040; ENSRNOP00060022562; ENSRNOG00060016359.
DR   Ensembl; ENSRNOT00065005526; ENSRNOP00065004022; ENSRNOG00065003778.
DR   GeneID; 54300; -.
DR   KEGG; rno:54300; -.
DR   UCSC; RGD:3686; rat.
DR   AGR; RGD:3686; -.
DR   CTD; 6559; -.
DR   RGD; 3686; Slc12a3.
DR   eggNOG; KOG2083; Eukaryota.
DR   InParanoid; P55018; -.
DR   OrthoDB; 5490251at2759; -.
DR   PhylomeDB; P55018; -.
DR   Reactome; R-RNO-426117; Cation-coupled Chloride cotransporters.
DR   PRO; PR:P55018; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015081; F:sodium ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015378; F:sodium:chloride symporter activity; IDA:UniProtKB.
DR   GO; GO:0008511; F:sodium:potassium:chloride symporter activity; IBA:GO_Central.
DR   GO; GO:0006884; P:cell volume homeostasis; IBA:GO_Central.
DR   GO; GO:0055064; P:chloride ion homeostasis; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IMP:RGD.
DR   GO; GO:0055075; P:potassium ion homeostasis; IBA:GO_Central.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0070294; P:renal sodium ion absorption; ISO:RGD.
DR   GO; GO:1904044; P:response to aldosterone; ISO:RGD.
DR   GO; GO:0002021; P:response to dietary excess; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0055078; P:sodium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   Gene3D; 1.20.1740.10; Amino acid/polyamine transporter I; 1.
DR   InterPro; IPR004841; AA-permease/SLC12A_dom.
DR   InterPro; IPR013612; AA_permease_N.
DR   InterPro; IPR018491; SLC12_C.
DR   InterPro; IPR002948; SLC12A3.
DR   InterPro; IPR004842; SLC12A_fam.
DR   NCBIfam; TIGR00930; 2a30; 1.
DR   PANTHER; PTHR11827:SF9; SOLUTE CARRIER FAMILY 12 MEMBER 3; 1.
DR   PANTHER; PTHR11827; SOLUTE CARRIER FAMILY 12, CATION COTRANSPORTERS; 1.
DR   Pfam; PF00324; AA_permease; 1.
DR   Pfam; PF08403; AA_permease_N; 1.
DR   Pfam; PF03522; SLC12; 2.
DR   PRINTS; PR01230; NACLTRNSPORT.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Chloride; Disulfide bond; Glycoprotein;
KW   Ion transport; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Sodium; Sodium transport; Symport; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN           1..1002
FT                   /note="Solute carrier family 12 member 3"
FT                   /id="PRO_0000178028"
FT   TOPO_DOM        1..135
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        136..165
FT                   /note="Discontinuously helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TRANSMEM        166..187
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        188..218
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        219..241
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        242..253
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        254..278
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TRANSMEM        279..301
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        302..336
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        337..358
FT                   /note="Discontinuously helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        359..369
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        370..391
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        392..451
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        452..475
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        476..505
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        506..520
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        521..525
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        526..542
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        543..565
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        566..585
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TRANSMEM        586..597
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   TOPO_DOM        598..1002
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          613..628
FT                   /note="Scissor helix"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         146
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         149
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         351
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         352
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         353
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         462
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         465
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         466
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         538
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         646
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         653
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         675
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         739
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         778
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   BINDING         779
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   MOD_RES         41
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P59158"
FT   MOD_RES         44
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P59158"
FT   MOD_RES         48
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P59158"
FT   MOD_RES         53
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MOD_RES         58
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   MOD_RES         124
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P59158"
FT   CARBOHYD        404
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   CARBOHYD        424
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   DISULFID        414..419
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   DISULFID        428..434
FT                   /evidence="ECO:0000250|UniProtKB:P55017"
FT   MUTAGEN         53
FT                   /note="T->A: Decreased response to intracellular chloride
FT                   depletion. Abolished response to intracellular chloride
FT                   depletion; when associated with A-58 and A-71."
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MUTAGEN         58
FT                   /note="T->A: Decreased response to intracellular chloride
FT                   depletion. Abolished response to intracellular chloride
FT                   depletion; when associated with A-53 and A-71."
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MUTAGEN         71
FT                   /note="S->A: Decreased response to intracellular chloride
FT                   depletion. Abolished response to intracellular chloride
FT                   depletion; when associated with A-53 and A-58."
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MUTAGEN         404
FT                   /note="N->Q: Abolished N-glycosylation, leading to reduced
FT                   localization to the cell membrane; when associated with Q-
FT                   424."
FT                   /evidence="ECO:0000269|PubMed:16887815"
FT   MUTAGEN         424
FT                   /note="N->Q: Abolsihed N-glycosylation, leading to reduced
FT                   localization to the cell membrane; when associated with Q-
FT                   404."
FT                   /evidence="ECO:0000269|PubMed:16887815"
SQ   SEQUENCE   1002 AA;  110554 MW;  1EAC70E86D542C9D CRC64;
     MAELPVTEMP GDALCSGRFT ISTLLGGDEP PPAACDNSQP SHLTHGSTLY LRTFGYNTID
     VVPAYEHYAN SALPGEPRKV RPTLADLHSF LKQEGSHLHA LAFDGRPGHE LTDGLVEDET
     GANSEKSPGE PVRFGWVKGV MIRCMLNIWG VILYLRLPWI TAQAGIVLTW LIILLSVMVT
     SITGLSISAI STNGKVKSGG TYFLISRSLG PELGGSIGLI FAFANAVGVA MHTVGFAETV
     RDLLQENGTP IVDPINDIRI IGVVTVTVLL AISLAGMEWE SKAQVLFFLV IMVSFANYLV
     GTLIPASKDK ASKGFYSYHG DIFVQNLVPD WRGIDGSFFG MFSIFFPSAT GILAGANISG
     DLKDPAVAIP KGTLMAIFWT TISYLAISAT IGSCVVRDAS GDVNDTITPG PGLCEGLACG
     YGWNFTECSQ QHSCRYGLIN YYQTMSMVSA FAPLITAGIF GATLSSALAC LVSAAKVFQC
     LCEDQLYPLI GFFGKGYGKN KEPVRGYLLA YAIAVAFIII AELNTIAPII SNFFLCSYAL
     INFSCFHASI TNSPGWRPSF RYYSKWAALF GAVISVVIMF LLTWWAALIA IGVVLFLLLY
     VIYKKPEVNW GSSVQAGSYN LALSYSVGLN EVEDHIKNYR PQCLVLTGPP NFRPALVDFV
     STFTQNLSLM ICGHVLIAPG KQRVPELRLI ASGHTKWLNK RKIKAFYSDV IAEDLRSGVQ
     ILMQASGLGR MKPNILVVGF KKNWQSAHPA TLEDYIGILH DAFDFNYGVC IMRMREGLNV
     SEALQTHTAP EALVQEEQTS TIFQSEQGKK TIDIYWLFDD GGLTLLIPYL LHRKKRWGKC
     KIRVFVGGQI NRMDEERKAI ISLLSKFRLG FHEVHVLPDI NQKPQVEHTK RFEDMIAPFR
     LNDGFKDEAT VAEMRRDYPW KISDEEINKN RIKSLRQVRL NEILLDYSRD AALIILTLPI
     GRKGKCPSSL YMAWLETLSQ DLSPPVLLIR GNQENVLTFY CQ
//
